Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Eloxx Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +1 vs. Q2 2022
- Shares held
- 12.7M
- −298.1K (−2.3%) vs. Q2 2022
- Total value
- $2.14M
- −$1.36M (−38.9%) vs. Q2 2022
- New holders
- 3
- 6 more added
- Sold out
- 2
- 11 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $34.7M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $62 |
| Q4 2023 | 4 | $109.0K |
| Q3 2023 | 18 | $2.50M |
| Q2 2023 | 16 | $924.2K |
| Q1 2023 | 19 | $671.5K |
| Q4 2022 | 19 | $476.7K |
| Q3 2022 | 32 | $2.14M |
| Q2 2022 | 32 | $3.51M |
| Q1 2022 | 36 | $8.42M |
| Q4 2021 | 39 | $11.7M |
| Q3 2021 | 41 | $26.0M |
| Q2 2021 | 47 | $33.2M |
| Q1 2021 | 38 | $28.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Eloxx Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,704,513 | $459.0K | 0.00% | −117,680−4.2% | Reduced |
| Menora Mivtachim Holdings Ltd. | 2,094,208 | $356.0K | 0.01% | 00.0% | Unchanged |
| American Financial Group Inc | 1,480,000 | $252.0K | 0.09% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $200.0K | 0.00% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,098,469 | $187.0K | 0.08% | +56,970+5.5% | Added |
| Altshuler Shaham Ltd | 1,004,963 | $153.0K | 0.00% | −72,698−6.7% | Reduced |
| Geode Capital Management, LLC | 807,678 | $137.0K | 0.00% | +5,265+0.7% | Added |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $99.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 357,243 | $61.0K | 0.00% | −1,435−0.4% | Reduced |
| Bridgeway Capital Management, LLC | 224,900 | $38.0K | 0.00% | −24,500−9.8% | Reduced |
| State Street Corp | 189,959 | $32.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 145,381 | $25.0K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 144,116 | $24.0K | 0.01% | +15,000+11.6% | Added |
| Renaissance Technologies LLC | 133,500 | $23.0K | 0.00% | −45,900−25.6% | Reduced |
| Vanguard Capital Wealth Advisors | 127,000 | $22.0K | 0.03% | −28,900−18.5% | Reduced |
| Northern Trust Corp | 123,669 | $21.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 58,622 | $10.0K | 0.00% | −53,138−47.5% | Reduced |
| Bank of America Corp | 58,023 | $10.0K | 0.00% | −66−0.1% | Reduced |
| Wells Fargo & Company | 46,703 | $8.00K | 0.00% | −30.0% | Reduced |
| National Asset Management, Inc. | 38,500 | $7.00K | 0.00% | +38,500 | New |
| Tower Research Capital LLC (TRC) | 19,280 | $3.00K | 0.00% | +6,265+48.1% | Added |
| Virtu Financial LLC | 14,931 | $3.00K | 0.00% | +14,931 | New |
| Jane Street Group, LLC | 18,520 | $3.00K | 0.00% | +18,520 | New |
| Advisor Group Holdings, Inc. | 12,359 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,176 | $1.00K | 0.00% | −4−0.1% | Reduced |
| BNP Paribas Arbitrage, SA | 489 | $83 | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 627 | $0 | 0.00% | −39,048−98.4% | Reduced |
| JPMorgan Chase & Co | 87 | $0 | 0.00% | +46+112.2% | Added |
| Credit Suisse AG | 5 | $0 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 179 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 460 | $0 | 0.00% | +400+666.7% | Added |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −49,300−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −21,295−100.0% | Sold out |
| B. Riley Wealth Management, Inc. | – | – | – | – | Not filed |